These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7010990)

  • 1. Prospective double-blind clinical trial of bovine, human, and rabbit thromboplastins in monitoring long-term oral anticoagulation.
    Boekhout-Mussert MJ; van der Kolk-Schaap PJ; Hermans J; Loeliger EA
    Am J Clin Pathol; 1981 Mar; 75(3):297-303. PubMed ID: 7010990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombin times: an evaluation of four thromboplastins and four machines.
    Starr H; Rhoades P; Lam-Po-Tang PR; Archer GT
    Pathology; 1980 Oct; 12(4):567-74. PubMed ID: 7465253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.
    Guglielmone HA; Vides MA
    Ann Biol Clin (Paris); 1990; 48(8):547-50. PubMed ID: 2288441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prothrombin time and its standardization].
    Kagawa K
    Rinsho Byori; 2002 Aug; 50(8):779-85. PubMed ID: 12373814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The calibration of rabbit tissue thromboplastins: experience of the Dutch Reference Laboratory for anticoagulant control.
    van den Besselaar AM; Hermans J; van der Velde EA; Bussemaker-Verduyn den Boer E; van Halem-Visser LP; Jansen-Grüter R; Loeliger EA
    J Biol Stand; 1986 Oct; 14(4):305-17. PubMed ID: 3558415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a standard and a sensitive thromboplastin in monitoring low intensity oral anticoagulant therapy.
    Brophy MT; Fiore LD; Lau J; Goodwin R; Lopez A; Deykin D
    Am J Clin Pathol; 1994 Jul; 102(1):134-7. PubMed ID: 8037160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of oral anticoagulants by the prothrombin time: a plea for uniformity.
    Bain B; Forster T; Sleigh B
    Med J Aust; 1978 Nov; 2(10):459-61. PubMed ID: 739933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of freeze-dried plasma prepared from patients on oral anticoagulants.
    Brozović M; Howarth DJ; van Halem Visser LP; Loeliger EA
    J Clin Pathol; 1973 Nov; 26(11):857-63. PubMed ID: 4797328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombin time standardization: report of the expert panel on oral anticoagulant control. The International Committee on Thrombosis and Haemostasis, The International Committee for Standardization in Hematology.
    Thromb Haemost; 1979 Dec; 42(4):1073-114. PubMed ID: 542923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical study monitoring low-intensity anticoagulant therapy with a standard-sensitivity thromboplastin.
    Brophy MT; Fiore LD; Lau J; Headley E; Allen M; Deykin D
    Arch Pathol Lab Med; 1993 Jun; 117(6):618-21. PubMed ID: 8503734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of thromboplastins used for oral anticoagulant control.
    Exner T; Rickard KA; Kronenberg H
    Pathology; 1980 Oct; 12(4):559-66. PubMed ID: 7465252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rabbit (to replace human) brain material in anticoagulant control.
    Allington MJ; Bolton FG
    Lancet; 1986 May; 1(8489):1088. PubMed ID: 2871349
    [No Abstract]   [Full Text] [Related]  

  • 13. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
    van den Besselaar AM
    J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "therapeutic range" of the one-stage prothrombin time in the control of anticoagulant therapy: the effect of different thromboplastin preparations.
    Bailey EL; Harper TA; Pinkerton PH
    Can Med Assoc J; 1971 Nov; 105(10):1041-3 passim. PubMed ID: 5150206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the behavior of normal factor IX and the factor IX Bm variant Hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sources.
    Lefkowitz JB; Monroe DM; Kasper CK; Roberts HR
    Am J Hematol; 1993 Jul; 43(3):177-82. PubMed ID: 8352232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The optimal therapeutic range in oral anticoagulation. History and proposal.
    Loeliger EA
    Thromb Haemost; 1979 Dec; 42(4):1141-52. PubMed ID: 396691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Variability of INR due to thromboplastin. Comparison of two recombinant thromboplastins and one rabbit thromboplastin].
    Renier JL; Baufine-Ducrocq H; Samama MM
    Ann Biol Clin (Paris); 1995; 53(6):353-6. PubMed ID: 8572381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imprecision of prothrombin time monitoring of oral anticoagulation. A survey of hospital laboratories.
    Ansell JE
    Am J Clin Pathol; 1992 Aug; 98(2):237-9. PubMed ID: 1510036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of Quick's prothrombin time test to oral anticoagulation. Influence of thromboplastin source and calcium chloride concentration.
    van den Besselaar AM
    Arch Pathol Lab Med; 1994 Feb; 118(2):145-9. PubMed ID: 8311653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative analysis of 2 thromboplastins].
    Silvino S; Evangelisti L; Camici M; Giordani R
    Minerva Med; 1998 Sep; 89(9):303-8. PubMed ID: 9856118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.